[Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination]

Mol Biol (Mosk). 2017 Nov-Dec;51(6):945-957. doi: 10.7868/S0026898417060076.
[Article in Russian]

Abstract

A study of the induction of broadly neutralizing antibodies (bNAbs) in HIV-infected patients and vaccinated subjects revealed the main criteria for the formation of bNAbs (the duration of exposure to a viral antigen, the effect of the diversity of HIV variants, and the removal of barriers associated with the Env-dependent defense mechanisms of HIV-1). Modified trimers of the HIV-1 envelope protein (Env) exposed on virus-like particles (VLP) have unique properties: they (i) modulate the exposure of binding sites (bs) of the CD4 receptor and co-receptor; (ii) create steric restrictions for contact with bNAbs; (iii) increase the Env presentation density, thus enhancing the immune response; (iv) form stable trimers that do not induce off-target immune responses; and (v) allow additional modifications to their structure and construction of a platform with immunostimulating molecules. Immunization using a heterologous subtype-cross prime-boost regime with modified trimeric Env is capable of inducing somatic hypermutation levels necessary for the formation of bNAbs.

Keywords: Env trimer; HIV-1; broadly neutralizing antibodies; protective neutralizing antibodies; virus-like particles.

Publication types

  • Review

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / genetics
  • AIDS Vaccines / immunology
  • Antibodies, Neutralizing / biosynthesis*
  • Antibodies, Neutralizing / chemistry
  • Antibodies, Neutralizing / genetics
  • Antigens, Viral / chemistry
  • Antigens, Viral / genetics
  • Antigens, Viral / immunology*
  • Binding Sites
  • CD4 Antigens / genetics
  • CD4 Antigens / immunology
  • Epitopes / chemistry
  • Epitopes / genetics
  • Epitopes / immunology
  • HIV Antibodies / biosynthesis*
  • HIV Antibodies / chemistry
  • HIV Antibodies / genetics
  • HIV Infections / immunology
  • HIV Infections / prevention & control*
  • HIV Infections / virology
  • HIV-1 / drug effects*
  • HIV-1 / immunology
  • Humans
  • Protein Multimerization
  • T-Lymphocytes / immunology
  • T-Lymphocytes / virology
  • Vaccination / methods
  • env Gene Products, Human Immunodeficiency Virus / chemistry
  • env Gene Products, Human Immunodeficiency Virus / genetics
  • env Gene Products, Human Immunodeficiency Virus / immunology*

Substances

  • AIDS Vaccines
  • Antibodies, Neutralizing
  • Antigens, Viral
  • CD4 Antigens
  • Epitopes
  • HIV Antibodies
  • env Gene Products, Human Immunodeficiency Virus